A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration
Chahua Huang; Yang Liu; Andrew Beenken; Lin Jiang; Xiang Gao; Zhifeng Huang; Anna Hsu; Garrett J. Gross; Yi-Gang Wang; Moosa Mohammadi; Jo El J. Schultz
Author Information: Department of Pharmacology and Cell Biophysics, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.